Skip to main content
. 2013 May 27;6:585–591. doi: 10.2147/OTT.S44406

Figure 1.

Figure 1

Progression-free survival curves for metastatic esophageal cancer patients treated with nanoparticle albumin-bound paclitaxel plus cisplatin (n = 33).